Arcturus Therapeutics Ltd. Capital Expenditures
Arcturus Therapeutics Ltd. reported Capital Expenditures of $78.00 thousand for the 3-month period ending 2019-03-31, per its 10-Q filed 2019-05-13.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2019-05-13
- Arcturus Therapeutics Ltd. payments to acquire property, plant, and equipment for the quarter ending 2019-03-31 was $78.00K, a 78.45% decline year-over-year.
- Arcturus Therapeutics Ltd. payments to acquire property, plant, and equipment for the quarter ending 2018-12-31 was $225.00K, a 49.01% increase year-over-year.
- Arcturus Therapeutics Ltd. payments to acquire property, plant, and equipment for the quarter ending 2018-09-30 was $253.00K, a 201.19% increase year-over-year.
- Arcturus Therapeutics Ltd. payments to acquire property, plant, and equipment for the quarter ending 2018-06-30 was $638.00K.
- Arcturus Therapeutics Ltd. payments to acquire property, plant, and equipment for fiscal 2018 was $1.48M, a 488.84% increase from fiscal 2017.
- Arcturus Therapeutics Ltd. payments to acquire property, plant, and equipment for fiscal 2017 was $251.00K.
| Period end | Payments to Acquire Property, Plant, and Equipment 3 month | Payments to Acquire Property, Plant, and Equipment 6 month | Payments to Acquire Property, Plant, and Equipment 9 month | Payments to Acquire Property, Plant, and Equipment 12 month | Payments to Acquire Property, Plant, and Equipment 12 month as first filed | Payments to Acquire Property, Plant, and Equipment 71 month |
|---|---|---|---|---|---|---|
| 2019-03-31 | $78.00K 10-Q · filed 2019-05-13 | $303.00K derived: sum of 2 quarters · filed 2019-05-13 | $556.00K derived: sum of 3 quarters · filed 2019-05-13 | $1.19M derived: sum of 4 quarters · filed 2019-05-13 | ||
| 2018-12-31 | $225.00K derived: 10-K 12 month − 6-K 9 month · filed 2019-03-18 | $478.00K derived: sum of 2 quarters · filed 2019-03-18 | $1.12M derived: sum of 3 quarters · filed 2019-03-18 | $1.48M 10-K · filed 2019-03-18 | ||
| 2018-09-30 | $253.00K derived: 6-K 9 month − 6-K 6 month · filed 2018-11-07 | $891.00K derived: sum of 2 quarters · filed 2018-11-07 | $1.25M 6-K · filed 2018-11-07 | $1.40M derived: sum of 4 quarters · filed 2019-05-13 | ||
| 2018-06-30 | $638.00K derived: 6-K 6 month − 10-Q 3 month · filed 2018-09-28 | $1.00M 6-K · filed 2018-09-28 | $1.15M derived: sum of 3 quarters · filed 2019-05-13 | $1.24M derived: sum of 4 quarters · filed 2019-05-13 | ||
| 2018-03-31 | $362.00K 10-Q · filed 2019-05-13 | $513.00K derived: sum of 2 quarters · filed 2019-05-13 | $597.00K derived: sum of 3 quarters · filed 2019-05-13 | |||
| 2017-12-31 | $151.00K derived: 10-K 12 month − 6-K 9 month · filed 2019-03-18 | $235.00K derived: sum of 2 quarters · filed 2019-03-18 | $251.00K 10-K · filed 2019-03-18 | |||
| 2017-09-30 | $84.00K derived: 6-K 9 month − 6-K 6 month · filed 2018-11-07 | $100.00K 6-K · filed 2018-11-07 | ||||
| 2017-06-30 | $16.00K 6-K · filed 2018-09-28 | |||||
| 2016-12-31 | $688.00K 20-F · filed 2018-05-14 | $74.00K 20-F · filed 2017-04-28 | ||||
| 2015-12-31 | $247.00K 20-F · filed 2018-05-14 | $181.00K 20-F · filed 2016-03-04 | ||||
| 2014-12-31 | $79.00K 20-F · filed 2017-04-28 | |||||
| 2013-12-31 | $39.00K 20-F · filed 2016-03-04 | $79.00K 20-F · filed 2014-03-28 | ||||
| 2012-12-31 | $0.00 20-F · filed 2015-02-27 | |||||
| 2011-12-31 | $24.00K 20-F · filed 2014-03-28 |